Pfizer and BioNTech Receive Expanded U.S. Emergency Use Authorization for an Additional COVID-19 Vaccine Booster in Individuals Aged 50 Years and Older
Medical Information
In order to provide you with relevant and meaningful content we need to know more about you.
Please choose the category that best describes you.
Información selecta para pacientes y cuidadores que se encuentra disponible en Español.
This content is intended for U.S. Healthcare Professionals. Would you like to proceed?
I am a U.S. Healthcare ProfessionalYes, I am a U.S. Healthcare Professional
SelectI am a U.S. Healthcare ProfessionalYes, I am a U.S. Healthcare ProfessionalI am a U.S. Patient / CaregiverNo, go back to the patient portal
SelectI am a U.S. Patient / CaregiverNo, go back to the patient portal